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1. Introduction  
In recent years, a rapid increase in microbes that are resistant to conventional antibiotics has 
been observed (Goffeau, 2008). Especially, the frequency of infections provoked by 
opportunistic fungal strains has increased dramatically. Even though the majority of 
invasive fungal infections are still due to the Aspergillus or Candida species, the spectrum of 
fungal pathogens has changed and diversified (Denning, 1991; Ellis et al., 2000; Odds et al., 
2003). Azoles that inhibit sterol formation and polyenes that bind to mature membrane 
sterols have been the mainstays regarding antifungal therapy for several decades (Kullberg 
& de Pauw, 1999; Sheehan et al., 1999). However, not only the emergence of fluconazole 
resistance among different pathogenic strains but also the high toxicity of amphotericin B 
(Alexander & Perfect, 1997; Mukherjee et al., 2003) has prompted research on new 
antifungal agents (Kontoyiannis et al., 2003). 
Bio-nanotechnology has emerged as an integration between biotechnology and 
nanotechnology for developing biosynthesis and environmental-friendly technology for 
synthesis of nanomaterials. We specifically regarded nanoparticles as clusters of atoms in 
the size of 1-100 nm. ‘Nano’ is a Greek word synonymous to dwarf meaning extremely 
small. The use of nanoparticles is gaining impetus in the present century as they posses 
defined chemical, optical and mechanical properties. Among them, the metallic 
nanoparticles are most promising as they contain remarkable antibacterial properties due to 
their large surface area to volume ratio, which is of interest to researchers due to the 
growing microbial resistance against metal ions, antibiotics, and the development of 
resistant strains (Rai et al., 2009; Gong et al., 2007). 
Different types of nanomaterials like copper, zinc, titanium (Schabes-Retchkiman et al., 2006), 
magnesium, gold (Gu et al., 2003), alginate (Ahmad et al., 2005) and silver have been 
developed but silver nanoparticles (Nano-Ag) have proved to be most effective as they exhibit 
potent antimicrobial efficacy against bacteria, viruses and eukaryotic micro-organisms. 
However, Nano-Ag used as a disinfectant drug also has some risks as the exposure to silver 
can cause argyrosis or argyria; it can be toxic to mammalian cells (Gong et al., 2007). 
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The current investigation supports the theory that the use of silver ions or metallic silver as 
well as Nano-Ag can be exploited in medicine for burn treatment, dental materials, coating 
stainless steel materials, textile fabrics, water treatment, sunscreen lotions, etc. and posses 
low toxicity to human cells, high thermal stability and low volatility (Duran et al., 2007). 
Many studies have shown the biological effects of Nano-Ag, however, its effects against 
fungal pathogens have not yet been fully studied. In this study, therefore, the antifungal 
properties and mechanism of actions of Nano-Ag against human pathogenic fungal strains 
were investigated. Furthermore, the therapeutic potential of Nano-Ag for treating fungal 
diseases in humans was suggested. 
 
2. Materials and methods 
2.1. Materials 
Amphotericin B, carbonyl cyanide m-chlorophenylhydrazone (CCCP), trehalase and RNase 
A were purchased from the Sigma Chemical Co.. Stock solutions of amphotericin B were 
prepared in dimethyl sulfoxide (DMSO), and stored at -20 C. For all the experiments, a final 
concentration of 2% DMSO was used as the solvent carrier. 
 
2.2. Preparation of Nano-Ag 
One hundred grams of solid silver were dissolved in 100 ml of 100% nitric acid at 90 C, and 
then 1 l of distilled water was added. By adding sodium chloride to the silver solution, the 
Ag ions were precipitated and then clustered together to form monodispersed nanoparticles 
in the aqueous medium. The sizes and morphology of Nano-Ag were examined by using a 
transmission electron microscope (TEM) (H-7600, HITACHI, LTD). The result showed that 
the Nano-Ag was in a spherical form and had an average size of 3 nm (Fig. 1). 
 Fig. 1. Transmission electron micrograph (TEM) of Nano-Ag. The bar corresponds to 20 nm. 
 
 
As the final concentration of colloidal silver was 60,000 ppm, this solution was diluted, and 
then samples of different concentrations were used to investigate the antifungal effects of 
Nano-Ag. 
 
2.3. Fungal strains and culture conditions 
A total of 44 strains of 2 fungal species were used in this study. Candida albicans (ATCC 
90028), Candida glabrata (ATCC 90030), Candida parapsilosis (ATCC 22019), and Candida krusei 
(ATCC 6258) were obtained from the American Type Culture Collection (ATCC) (Manassas, 
VA, USA). Clinical isolates of Candida spp. were obtained from the Department of 
Laboratory Medicine, Chonnam National University Medical School (Gwangju, Korea), and 
clinical isolates of Trichophyton mentagrophytes were obtained from the Institute of Medical 
Mycology, Catholic Skin Clinic (Daegu, Korea). Candida spp. and Trichophyton 
mentagrophytes were cultures in a Sabouraud dextrose agar (SDA) and a potato dextrose agar 
(PDA) at 35 C, respectively. 
 
2.4. Antifungal susceptibility testing 
The minimum inhibitory concentration (MIC) for Candida spp. and T. mentagrophytes was 
determined by a broth microdilution method based on the National Committee for Clinical 
Laboratory Standards (NCCLS; now renamed as Clinical and Laboratory Standards Institute, 
CLSI, 2000) method outlined in documents M-27A and M-38P, respectively. An RPMI 1640 
medium buffered to pH 7.0 with 3-(N-morpholino) propanesulfonic acid (MOPS) was used 
as the culture medium, and the inoculum size of Candida spp. was 0.5 х 103 to 2.5 х 103 
cells/ml, and that of T. mentagrophytes was 0.4 х 104 to 5 х 104 cells/ml. The microdilution 
plates inoculated with fungi were incubated at 35 C, and the turbidity of the growth control 
wells was observed every 24 hrs. The 80% inhibitory concentration (IC80) was defined as the 
lowest concentration that inhibited 80% of the growth as determined by a comparison with 
the growth in the control wells. The growth was assayed with a microplate reader (Bio-Tek 
Instruments, Winooski, VT, USA) by monitoring absorption at 405 nm. In the current study, 
amphotericin B and fluconazole were used as a positive control toward fungi; amphotericin 
B is a fungicidal agent widely used in treating serious systemic infections (Hartsel & Bolard, 
1996), and fluconazole is used in the treatment of superficial skin infections caused by 
dermatophytes and Candida species (Amichai & Grunwald, 1998). 
 
2.5. The effect on the dimorphic transition of C. albicans 
C. albicans cells were maintained by periodic subculturing in a liquid yeast 
extract/peptone/dextrose (YPD) medium. Cultures of yeast cells (blastoconidia) were 
maintained in a liquid YPD medium at 37 C. To induce mycelial formation, cultures were 
directly supplemented with 20% of fetal bovine serum (FBS). The dimorphic transition in C. 
albicans was investigated from cultures containing 2 mg/ml of Nano-Ag (at the IC80), which 
were incubated for 48 hrs at 37 C (Jung et al., 2007; Sung et al., 2007). The dimorphic 
transition to mycelial forms was detected by phase contrast light microscopy (NIKON, 
ECLIPSE TE300, Japan). 
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2.6. Hemolytic activity assay 
The hemolytic effect of Nano-Ag was examined by measuring the release of hemoglobin 
from a 4% suspension of fresh human red blood cells (hRBCs). The hRBCs were washed 
with phosphate-buffered saline (PBS: 35 mM phosphate buffer/150 mM NaCl, pH 7.4). 
One–hundred microliters of hRBC suspension was added to the 96-well microtiter plates, 
and then 100 μl of the compound solution in PBS was mixed into each well. After incubating 
the mixtures for 1 hr at 37 C, the mixtures were centrifuged at 1,500 rpm for 10 min, and the 
aliquots were transferred to new 96-well microtiter plates. The absorbance of the aliquots 
was measured at 414 nm by using a microtiter ELISA Reader. Hemolytic rates of 0 and 100% 
were determined in PBS and 0.1% Triton X-100, respectively (Park et al., 2003). The 
percentage of hemolysis was calculated by employing the following equation:  
 
Percentage hemolysis = [(Abs414 nm in the compound solution – Abs414 nm in PBS)/(Abs414 nm      
in 0.1% Triton X-100 – Abs414 nm in PBS)] х 100. 
 
2.7. Flow cytometric analysis for plasma membrane potential 
For analysis of the membrane integrity after the treatment of Nano-Ag, log-phased cells of 
C. albicans (1 х 108 cells), cultured in a YPD medium, were harvested and resuspended with 1 
ml of a fresh YPD medium, containing 30 g/ml of Nano-Ag (at 15 times the MIC) or 10 M 
of CCCP, used as a positive control. After incubation for 3 hrs, the cells were washed three 
times with PBS. To detect any depolarization of the cell membrane, 1 ml of PBS, containing 
50 µg of bis-(1,3-dibutylbarbituric acid) trimethine oxonol [DiBAC4(3)], was added and the 
samples were incubated for 1 hr at 4C in the dark (Liao et al., 1999). Flow cytometric 
analysis was performed using a FACSCalibur flow cytometer. 
 
2.8. Measurement of plasma membrane fluorescence intensity 
The fluorescence intensity from exponential C. albicans cells labeled by 1,6-diphenyl-1,3,5-
hexatriene (DPH) was used to monitor changes in membrane dynamics. The cells (1 х 108 
cells in a YPD medium), containing 20, 40, 60 and 80 μg/ml of Nano-Ag or amphotericin B, 
were incubated at a physiological temperature of 28C on a rotary shaker at 140 rpm for 2 
hrs. The control cells were incubated without a compound. The cells were fixed with 
formaldehyde (0.37%, v/v) for 45 min and they were collected by centrifugation at 3,000 
rpm, then washed several times with PBS buffer (pH 7.4), and the pellets were frozen in 
liquid nitrogen. For DPH labeling, the pellets were resuspended in PBS buffer and incubated 
at 28C for 45 min in the presence of 0.6 mM of DPH, followed by several washings in PBS 
buffer. The steady-state fluorescence intensity was measured by using a SHIMADZU RF-
5301PC spectrofluorophotometer at 350 nm excitation and 425 nm emission wavelengths 
(Fernandes et al., 2000). The results represent the average of the triplicate measurements 
from three independent assays. 
 
2.9. Determining released glucose and trehalose 
Fungal strains were grown at 28C in a YPD medium. C. albicans cells were washed three 
times with PBS, and then 1 ml of the C. albicans cell suspension (1 х 108 cells), containing 20 
g/ml of Nano-Ag (at 20 times the MIC), was incubated for 2 hrs at 28C in PBS. The 
negative control was incubated without Nano-Ag, and a positive control was incubated 
 
with 100 g/ml of amphotericin B (at 20 times the MIC). The fungal cells were settled by 
centrifugation (12,000 rpm for 20 min). The pellets were dried to calculate their dry weight 
and supernatants were transferred to a new tube. Released glucose and trehalose-containing 
supernatants were added to 0.05 units of trehalase. After 1 hr of enzymatic reaction at 37C, 
the reaction suspension was mixed with water and 16% DNS reagent (3,5-dinitrosalicylic 
acid 1%, NaOH 2%, sodium potassium tartrate 20%) was added. For the reaction of glucose 
with the DNS reagent, the mixture was boiled for 5 min and cooled. Color formations were 
measured at 525 nm. The results represent the average of the measurements conducted in 
triplicate of three independent assays. 
 
2.10. Transmission electron microscopy (TEM) 
Log-phased cells of C. albicans (1 х 108 cells) cultured in a YPD medium, were harvested and 
incubated in the presence of several different amounts of Nano-Ag for 24 hrs at 28C. TEM 
was used as a complementary technique to examine sections of the treated cells, using 
standard procedures for fixing and embedding sensitive biological samples, which are 
described elsewhere (Osumi, 1998; Mares et al., 1998). 
 
2.11. Flow cytometric analysis for a fungal cell cycle 
Log-phased cells of C. albicans (1 х 108 cells) cultured in a YPD medium, were harvested and 
treated with 40 g/ml of Nano-Ag (at 20 times the MIC). After incubation for 8 hrs, the cells 
were washed with PBS and fixed with 70% ethanol overnight at 4C. The cells were treated 
with 200 µg/ml of RNase A and the mixture was left to react for 2 hrs at 37C. For DNA 
staining, 50 µg/ml of propidium iodide (PI) were added and incubated for 1 hr at 4C in the 
dark (Green et al., 1999). Flow cytometric analysis was performed by a FACSCalibur flow 
cytometer. The values represent the average of the measurements conducted in triplicate of 
three independent assays. 
 
3. Results and discussion 
3.1. Antifungal activity of Nano-Ag 
In the past, silver has been in use for the treatment of burns or chronic wounds. In the 1940s, 
however, after penicillin was introduced, the use of silver for the treatment of bacterial 
infections decreased (Hugo & Russell, 1982; Demling & DeSanti, 2001; Chopra, 2007). 
Silver again came in picture in the 1960s when Moyer introduced the use of 0.5% silver 
nitrate for the treatment of burns. He proposed that this solution does not interfere with 
epidermal proliferation and possess antibacterial properties against Staphylococcus aureus, 
Pseudomonas aeruginosa and Escherichia coli (Moyer et al., 1965; Bellinger & Conway, 1970). In 
1968, silver nitrate was combined with sulfonamide to form silver sulfadazine cream, which 
served as a broad-spectrum antibacterial agent and was used for the treatment of burns. 
Silver sulfadazine is effective against various bacterial strains like E. coli, S. aureus, Klebsiella 
sp., and Pseudomonas sp. (Rai et al., 2009). It also possesses some antifungal and antiviral 
activities (Fox & Modak, 1974). Recently, due to the emergence of antiobiotic-resistant 
bacteria and limitations of the use of antibiotics clinicians have returned to using silver 
wound dressings, containing varying level of silver (Gemmell et al., 2006; Chopra, 2007). For 
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these reasons, the antifungal activity and its mechanism of silver, Nano-Ag specifically, was 
investigated. 
Nano-Ag, in an IC80 range of 1-25 µg/ml, showed significant antifungal activity against T. 
mentagrophytes and Candida species. Toward all fungal strains, Nano-Ag exhibited similar 
activity with amphotericin B, showing IC80 values of 1-5 µg/ml, but more potent activity 
than fluconazole, showing IC80 values of 10-30 µg/ml. However, this compound exhibited 
less potent activity than amphotericin B, showing IC80 values of 2-4 µg/ml for C. parapsilosis 
and C. krusei (Table 1). 
 
Fungal strains 
(no. of strains) 
IC80 (µg/ml) 
Nano-Ag Amphotericin B Fluconazole 
C. albicans (4) 2-4 5 10-16 
C. tropicalis (2) 7 2-4 13 
C. glabrata (4) 1-7 2 10-16 
C. parapsilosis (3) 4-25 2 13 
C. krusei (1) 13 4 13 
T. mentagrophytes (30) 1-4 1-2 20-30 
Table 1. Antifungal activity of Nano-Ag. 
 
In order to elucidate the antifungal activity of Nano-Ag, the dimorphic transition of C. 
albicans, induced by Nano-Ag, was investigated. The dimorphic transition of C. albicans from 
yeast form to mycelial form is responsible for pathogenicity, with mycelial shapes being 
predominantly found during the invasion of host tissue. A mycelial form can be induced by 
temperature, pH, and serum (McLain et al., 2000). As shown in Fig. 2, the serum-induced 
mycelia were significantly inhibited from extending and forming in the presence of Nano-
Ag (Fig. 2C), but the mycelia formed was normal in the absence of Nano-Ag (Fig. 2B).  
 
 Fig. 2. The effect of Nano-Ag on the dimorphic transition in C. albicans. (A) Yeast control 
without 20% FBS and Nano-Ag, (B) Cells treated with only 20% FBS, (C) Cells treated with 2 
μg/ml of Nano-Ag. 
 
These results confirmed the antifungal activity of Nano-Ag and suggested that Nano-Ag can 
be a potential compound in the treatment of fungal infectious diseases. 
 
3.2. Hemolytic activity of Nano-Ag against human erythrocytes 
Many antimicrobial agents are limited regarding clinical applications, as they can induce 
cytolysis of human cells. The hemolytic activity of Nano-Ag was investigated as an indicator 
 
of its cytotoxicity to mammalian cells. The hemolytic activity was evaluated by the 
percentage of hemolysis in the concentration range of 1.25-10 μg/ml. The result showed that 
Nano-Ag caused 6% lysis of erythrocytes at a concentration of 10 μg/ml, whereas 
amphotericin B induced 10% lysis at the same level (Table 2). 
 
Compound % Hemolysis (μg/ml) 10 5 2.5 1.25 
Nano-Ag 6 0 0 0 
Amphotericin B 10 0 0 0 
Table 2. Hemolytic activity of Nano-Ag against human erythrocytes. 
 
This result suggested that Nano-Ag could be applied to therapeutic agents regarding human 
fungal diseases with low cytotoxicity. 
 
3.3. Changes of plasma membrane potential induced by Nano-Ag 
To assess whether Nano-Ag can affect the function of a fungal plasma membrane, the 
dissipation of the fungal plasma membrane potential was investigated. C. albicans cells were 
cultured in the presence of Nano-Ag or CCCP used as a positive control, and the amounts of 
accumulated DiBAC4(3) in the cells were measured via flow cytometry by staining with 
DiBAC4(3). CCCP is an H+ ionophore which dissipates the H+ gradient and thus uncouples 
electron transport from ATP synthesis (Ghoul et al., 1989). DiBAC4(3) has a high voltage 
sensitivity and it enters depolarized cells, where it binds to lipid-rich intracellular 
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these reasons, the antifungal activity and its mechanism of silver, Nano-Ag specifically, was 
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C. parapsilosis (3) 4-25 2 13 
C. krusei (1) 13 4 13 
T. mentagrophytes (30) 1-4 1-2 20-30 
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compounds. FL2-H indicates the log fluorescent intensity of DiBAC4(3), and y-axis indicates 
cell numbers (events). 
 
3.4. Changes in the plasma membrane dynamics of fungal cells induced by Nano-Ag 
The effect of Nano-Ag on the fungal plasma membrane was further investigated by using 
DPH as a membrane probe. If the antifungal activities exerted by Nano-Ag on C. albicans are 
at the level of the cell plasma membrane, DPH, which can interact with an acyl group of the 
plasma membrane lipid bilayer, can not be inserted into the membrane. As shown in Fig. 4, 
the plasma membrane DPH fluorescence anisotropy was significantly decreased by 
increasing the concentrations of Nano-Ag or amphotericin B. This is consistent with the 
disruption of the plasma membrane by Nano-Ag as well as by a positive control, 
amphotericin B. 
 
 Fig. 4. DPH fluorescence anisotropy after the addition of Nano-Ag or amphotericin B. The 
error bars represent the standard deviation (SD) values for three independent experiments, 
performed in triplicate. 
 
3.5. Intracellular glucose and trehalose release induced by Nano-Ag 
The ability of Nano-Ag to disturb the integrity of the plasma membrane of fungal cells was 
also assessed by measuring the glucose and trehalose released in cell suspensions which 
were exposed to this compound. Trehalose can protect proteins and biological membranes 
from inactivation or denaturation caused by a variety of stress conditions, including 
desiccation, dehydration, heat, cold, oxidation, and toxic agents in yeast (Alvarez-Peral et al., 
2002; Elbein et al., 2003). The result showed that Nano-Ag or amphotericin B-treated cells 
both accumulated more intracellular glucose and trehalose than the compound-untreated 
cells. In addition, these cells also increased extracellular glucose and trehalose than the 
 
compound-untreated cells. The extracellular glucose and trehalose, induced by 
amphotericin B, were measured as being 27.4 µg per fungal dry weight of 1 mg. The 
extracellular glucose and trehalose amounts, however, induced by Nano-Ag were measured 
as being 30.3 µg per fungal dry weight of 1 mg. This rate was significantly higher than that 
induced in the compound-untreated cells (Table 3). The result suggests that it may be one of 
several intracellular components released during membrane disruption by Nano-Ag. As for 
the mechanism by which Nano-Ag breaks down the membrane permeability barrier, it is 
possible that Nano-Ag perturbs the membrane lipid bilayers, causing the leakage of ions 
and other materials as well as forming pores and dissipating the electrical potential of the 
membrane. 
 
 
Amounts of trehalose and glucose 
concentrations (μg/mg) 
Intracellular glucose 
and trehalose 
Released glucose and 
trehalose 
Control 7.2 6.8 
Nano-Ag 16.1 30.3 
Amphotericin B 20.5 27.4 
Table 3. The concentrations of trehalose and glucose from C. albicans by Nano-Ag and 
amphotericin B. 
 
3.6. Transmission electron microscopic (TEM) analysis 
TEM was used to evaluate the ability of Nano-Ag to disrupt the fungal envelope structure. 
The results showed that the Nano-Ag-treated fungal cells showed significant damage, which 
was characterized by the formation of a “pit” in their cell walls and pores in their plasma 
membrane (Fig. 5). 
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 Fig. 5. Transmission electron micrograph (TEM) of C. albicans cells. C. albicans were 
incubated in the presence of different amounts of Nano-Ag for 24 hrs at 28 C. The bar 
marker represents 1 µm. (A) Control, (B) Cells treated with 170 µg/ml of Nano-Ag, (C) Cells 
treated with 400 µg/ml of Nano-Ag. 
 
3.7. The arrest of fungal cell cycle induced by Nano-Ag 
In order to elucidate the physiological changes of the fungal cells induced by Nano-Ag, a 
flow cytometric analysis of the cell cycle was performed. The cells were cultured in the 
presence or absence of Nano-Ag and their DNA content was determined via flow cytometry 
by staining with propidium iodide (PI). PI is a DNA-staining dye that intercalates between 
the bases of DNA or RNA molecules (Tas & Westerneng, 1981). As shown in Fig. 6, the 
percentage of cells in the G2/M phase increased by 15%, while that in the G1 phase 
significantly decreased by about 20% in the presence of Nano-Ag. This data suggests that 
Nano-Ag inhibited some cellular processes which are involved in normal bud growth. Endo 
et al. have reported that the inhibition of bud growth correlates with membrane damage 
 
(Endo et al., 1997). Therefore, this report suggests that Nano-Ag inhibits the normal budding 
process, probably through the destruction of membrane integrity. 
 
 Fig. 6. The effects of Nano-Ag on the process of the cell cycle of C. albicans. C. albicans were 
incubated in the presence of Nano-Ag for 8 hrs at 28 C. FL2-H indicates the fluorescent 
intensity of PI, and y-axis indicates cell numbers (events). (A) FACS diagram of cell cycle; (a) 
Control without Nano-Ag, (b) Cells treated with 40 μg/ml Nano-Ag, (B) A histogram 
indicating the percentage of each cell cycle progress. 
 
4. Conclusion 
Many studies have shown the antimicrobial effects of Nano-Ag (Klasen, 2000; 
Russell & Hugo, 1994; Silver, 2003), but the effects of Nano-Ag against fungal 
pathogens of the skin, including clinical isolates of T. mentagrophytes and Candida 
species are mostly unknown. The primary significance of this study is the 
observation that Nano-Ag can inhibit the growth of dermatophytes, which cause 
superficial fungal infections (Kim et al., 2008). Nano-Ag also exhibited potent 
antifungal effects, probably through destruction of membrane integrity (Kim et al., 
2009). To the author’s knowledge, this is the first study to apply Nano-Ag 
successfully to dermatophytes and pathogenic fungal strains. Secondly, the fact 
that preparation method of Nano-Ag described here is cost-effective is also of 
importance. Therefore, it can be expected that Nano-Ag may have potential as an 
anti-infective agent for human fungal diseases. 
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